Clinical Trial Update: S9923 R115777 in Treating Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of tipifarnib (R115777) for advanced colorectal cancer has completed; this is an update on the S9923 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED